A retrospective, pharmacokinetic study of peramivir in critically ill children treated for influenza A or B viral infections
Latest Information Update: 19 Sep 2019
Price :
$35 *
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Pharmacokinetics
- 19 Sep 2019 New trial record
- 12 Sep 2019 Pharmacokinetic results published in the Pharmacotherapy.